Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Current Leases (2019 - 2025)

Historic Current Leases for International Stem Cell (ISCO) over the last 7 years, with Q3 2025 value amounting to $383000.0.

  • International Stem Cell's Current Leases rose 2158.73% to $383000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $383000.0, marking a year-over-year increase of 2158.73%. This contributed to the annual value of $330000.0 for FY2024, which is 1956.52% up from last year.
  • Per International Stem Cell's latest filing, its Current Leases stood at $383000.0 for Q3 2025, which was up 2158.73% from $371000.0 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Current Leases registered a high of $383000.0 during Q3 2025, and its lowest value of $179000.0 during Q4 2021.
  • For the 5-year period, International Stem Cell's Current Leases averaged around $281210.5, with its median value being $288000.0 (2024).
  • Per our database at Business Quant, International Stem Cell's Current Leases crashed by 4826.59% in 2021 and then soared by 2849.16% in 2022.
  • Quarter analysis of 5 years shows International Stem Cell's Current Leases stood at $179000.0 in 2021, then grew by 28.49% to $230000.0 in 2022, then rose by 20.0% to $276000.0 in 2023, then rose by 19.57% to $330000.0 in 2024, then grew by 16.06% to $383000.0 in 2025.
  • Its Current Leases was $383000.0 in Q3 2025, compared to $371000.0 in Q2 2025 and $361000.0 in Q1 2025.